Latest news with #AnandIyer
Yahoo
25-03-2025
- Health
- Yahoo
Welldoc Earns 2025 BIG Artificial Intelligence Excellence Award
Recognition Reinforces Welldoc's Position as a Digital Health Leader Driving AI Innovation in Healthcare COLUMBIA, Md., March 25, 2025--(BUSINESS WIRE)--Welldoc®, a digital health leader revolutionizing cardiometabolic care, today announced that it has been named a winner in the 2025 Artificial Intelligence Excellence Awards program presented by the Business Intelligence Group. The Artificial Intelligence Excellence Awards recognize groundbreaking advancements in AI and companies that have demonstrated a commitment to innovation and significant measurable impact. Welldoc has been named an Artificial Intelligence Excellence Award winner in the Health Organization category for the AI powering its digital health platform. The platform empowers individuals with personalized, AI-driven digital coaching to enable self-management of cardiometabolic conditions, positive lifestyle changes and improved overall health and outcomes. The scalable, cost-effective, multi-condition platform holistically supports complex combinations of some of the most prevalent cardiometabolic conditions, including prediabetes, diabetes, hypertension, heart failure and weight management, including GLP-1 and obesity medication support. Welldoc continues to advance its AI with even more precise personalization by integrating technology like real-time sensors. The company's latest AI excels by correlating insights across a broad spectrum of health data, surpassing the capabilities of other solutions. Welldoc's dynamic, adaptive AI models, powered by evidence-based guidelines and proprietary large sensor models, translate complex numerical data into personalized insights and coaching, while also maintaining clinical integrity and adhering to AI-specific regulatory guidelines. "Welldoc is committed to driving meaningful AI innovation in healthcare," said Anand Iyer, PhD, MBA, Chief AI Officer of Welldoc. "This award validates the important work we are doing to build more sophisticated personalization and help individuals improve their health." With more than 50 newly issued AI patents, complementing its 11 diabetes Federal Drug Administration (FDA) 510(k) Class II clearances, Welldoc is uniquely positioned to lead next-generation digital health and continue forging strong partnerships with life science and device leaders to develop innovative combination solutions in cardiometabolic health, prescription drug use-related software (PDURS) and software in a medical device (SiMD). "The AI industry is evolving rapidly, and it is through the efforts of companies like Welldoc that we see real-world applications driving change," said Russ Fordyce, CEO of the Business Intelligence Group. "Welldoc's work exemplifies the kind of innovation and leadership that is shaping the future of artificial intelligence." About WelldocWelldoc®, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc's comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. Welldoc is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. The company partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs. Welldoc has achieved 11 510(k) clearances for diabetes functionality within its digital health platform, and an IP portfolio of 50+ patents for its advanced AI and first-in-class tech. With over 90 clinical publications, Welldoc has also built an extensive library of clinical research, including many publications focused on the value of combining CGM with AI-powered digital health solutions. Welldoc is an industry thought leader and has been showcased in prestigious conferences and publications, including South by Southwest, The Wall Street Journal and The Economist. The company has been named the "Best Overall Digital Health Company" by MedTech Breakthrough for the past two years and was selected as a winner of the 2025 AI Excellence Awards by Business Intelligence Group, 2024 Healthcare AI Impact Awards, Innovation Awards by Business Intelligence Group and Top 100 Healthcare Technology Companies by the Healthcare Technology Report. For more information, visit Follow us on LinkedIn and X. About Business Intelligence GroupThe Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers. Visit View source version on Contacts CTD CommsMegan Prock McGrath573-578-1184megan@ Sign in to access your portfolio
Yahoo
19-03-2025
- Business
- Yahoo
Welldoc Achieves 50+ Patents, Unveiling "CGM-GPT" for Advanced Glucose Prediction
Digital Health Leader's Innovation in Real-Time Sensor-Based AI Sets New Standards for Personalized Cardiometabolic Care COLUMBIA, Md., March 19, 2025--(BUSINESS WIRE)--Welldoc®, a digital health leader revolutionizing cardiometabolic care, today announced the issuance of four new patents, marking its 54th patent grant. This milestone underscores Welldoc's relentless commitment to innovation and leadership in leveraging artificial intelligence (AI) and advanced predictive capabilities based on real-time sensor data. The company's digital health platform empowers individuals with personalized AI-driven digital coaching to enable self-management of cardiometabolic conditions, positive lifestyle changes and improved overall health and outcomes. The new patents focus on Welldoc's unique approach to combining dense, sensor-based data specifically collected from Continuous Glucose Monitors (CGM), with AI to predict future engagement levels, health metrics and improved outcomes. This includes the development of a "CGM-GPT" model using generative AI techniques to predict future glucose values. "Securing 50+ patents is a testament to the hard work of our talented team in the U.S. and India and their dedication to driving AI innovation in digital health," said Kevin McRaith, President and CEO of Welldoc. "We are proud to have built a strong foundation of intellectual property that enables us to deliver impactful cardiometabolic care solutions and drive continuous innovation in our product development. Protecting the underlying algorithms and functions that power the Welldoc platform is crucial to our ability to partner with healthcare industry leaders and create a more sophisticated, personalized experience for our users." Welldoc continues to expand its intellectual property portfolio, securing protections for a wide range of AI-driven and CGM-focused innovations. These include machine learning algorithms based on aggregated, complex health data—such as medications, symptoms and device data—and generative AI algorithms for curated content delivery along with first-in-class advanced capabilities in quantitative prediction, including weight and glucose levels. "It is well-known that generative, transformer-based AI models—most commonly known as large language models—may not work well for complex mathematical applications. They were designed to predict a series of words rather than numerical values," said Anand Iyer, PhD, MBA, Chief AI Officer of Welldoc. "We are creating our own specialized large sensor models, designed to tackle complex mathematical tasks, such as predicting future glucose levels, ultimately focused on advanced improvement to personalized health." Welldoc currently has patents granted and pending in the U.S. and globally, with plans to expand. About WelldocWelldoc®, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc's comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. Welldoc is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. The company partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs. Welldoc has achieved 11 510(k) clearances for diabetes functionality within its digital health platform, and an IP portfolio of 50+ patents for its advanced AI and first-in-class tech. With over 90 clinical publications, Welldoc has also built an extensive library of clinical research, including many publications focused on the value of combining CGM with AI-powered digital health solutions. Welldoc is an industry thought leader and has been showcased in prestigious conferences and publications, including South by Southwest, The Wall Street Journal and The Economist. The company has been named the "Best Overall Digital Health Company" by MedTech Breakthrough for the past two years and was selected as a winner of the 2024 Healthcare AI Impact Awards, Innovation Awards by Business Intelligence Group and Top 100 Healthcare Technology Companies by the Healthcare Technology Report. For more information, visit Follow us on LinkedIn and X. View source version on Contacts CTD CommsMegan Prock McGrath573-578-1184megan@
Times of Oman
05-03-2025
- Business
- Times of Oman
Shabiba Forum 2025: Empowering Omani Youth to Shape the Future
MUSCAT: The Shabiba Forum 2025, Oman's premier youth-focused platform, is dedicated to empowering young minds through open dialogue, innovation, and collaboration. Serving as a catalyst for meaningful change, the forum bridges the gap between youth aspirations and national development goals. Set to take place on May 21, 2025, this dynamic event will bring together over 250 next-generation leaders, industry experts, and policymakers for insightful discussions on Oman's socio-economic future. Through thought-provoking conversations, interactive sessions, and strategic networking, the Shabiba Forum aims to inspire action and drive impactful solutions for the nation's youth and the broader economy. Organised by Muscat Media Group, Shabiba, and Gulf Leaders Circle, with Times of Oman & Al Shabiba as media partners and Manzana as the event partner, this dynamic platform is dedicated to fostering open discussions, innovative solutions, and actionable insights that will empower Omani youth to drive progress and shape the nation's future. What to Expect The Shabiba Forum 2025 will feature an exciting lineup of keynote speeches, expert panel discussions, and interactive conversations focused on shaping Oman's future. Attendees will gain valuable insights on critical topics, including Omani Youth & Vision 2040, which explores strategies for preparing future leaders and the workforce, and Entrepreneurship & Innovation, emphasising the role of young entrepreneurs in job creation. Discussions will also cover Omanisation in the Digital Age, highlighting new skills and career opportunities, as well as Sustainability & the Green Economy, addressing job creation in a rapidly evolving market. Additionally, sessions will focus on Bridging the Skills Gap, aligning education with industry needs, and Expanding Oman's Startup Ecosystem, tackling challenges and opportunities for young entrepreneurs. Another key theme will be Corporate Mentorship & Leadership Development, empowering the next generation of professionals through mentorship and career guidance. Who Can Attend? The Shabiba Forum 2025 is designed for young Omanis (18-35) who aspire to be entrepreneurs, innovators, and industry leaders, as well as business executives, corporate mentors, and decision-makers seeking to support youth development. The forum will also bring together government officials and policymakers working on initiatives for youth empowerment, alongside investors, venture capitalists, and financial institutions looking to support emerging talent and startups. Academics, educators, and training experts focused on shaping the future workforce will also find value in the discussions. Additionally, SMEs and business owners invested in driving youth employment and economic growth are encouraged to participate in this transformative event. Be part of this exciting event that will redefine opportunities for Omani youth. For more details, contact: Anand Iyer – [email protected] | +968 99219268 Kalpesh Adhia – [email protected] | +968 95511335 Muna Al Zadjali – [email protected] | +968 9399 3334
